Kristin Agopian, PhD

TitleSenior Licensing Officer
InstitutionUniversity of California San Francisco
DepartmentInnovation Ventures
Address600 16th St
San Francisco CA 94158
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Kristin manages a portfolio of technologies and works with UCSF faculty and staff to develop and commercialize their inventions. She drafts and negotiates many agreements, including outgoing material transfer, confidentiality, inter-institutional, option and license agreements.

    Kristin has been managing intellectual property for UCSF since August 2008. She was previously a Senior Analyst with Health Advances, a healthcare business strategy consulting firm. She was also a Christine Mirzayan Science & Technology Policy Fellow at the National Academies, where she worked on improvements to university-industry relationships. Kristin holds a Ph.D. in Virology from Harvard University and an A.B. in Molecular Biology from Princeton University. She has research experience in HIV pathogenesis, cell signaling, cell biology, mouse genetics and Drosophila development and speciation.

    Kristin is excited about helping UCSF researchers succeed in translation of their cutting edge research into technologies that will advance health worldwide.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Mukerji J, Olivieri KC, Misra V, Agopian KA, Gabuzda D. Proteomic analysis of HIV-1 Nef cellular binding partners reveals a role for exocyst complex proteins in mediating enhancement of intercellular nanotube formation. Retrovirology. 2012 Jun 22; 9:33. PMID: 22534017; PMCID: PMC3382630.
    2. Olivieri KC, Agopian KA, Mukerji J, Gabuzda D. Evidence for adaptive evolution at the divergence between lymphoid and brain HIV-1 nef genes. AIDS Res Hum Retroviruses. 2010 Apr; 26(4):495-500. PMID: 20377428; PMCID: PMC2933169.
    3. Gorry PR, Dunfee RL, Mefford ME, Kunstman K, Morgan T, Moore JP, Mascola JR, Agopian K, Holm GH, Mehle A, Taylor J, Farzan M, Wang H, Ellery P, Willey SJ, Clapham PR, Wolinsky SM, Crowe SM, Gabuzda D. Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote. Virology. 2007 May 25; 362(1):163-78. PMID: 17239419; PMCID: PMC1973138.
    4. Agopian K, Wei BL, Garcia JV, Gabuzda D. CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable. Virology. 2007 Feb 05; 358(1):119-35. PMID: 16979207; PMCID: PMC1995023.
    5. Agopian K, Wei BL, Garcia JV, Gabuzda D. A hydrophobic binding surface on the human immunodeficiency virus type 1 Nef core is critical for association with p21-activated kinase 2. J Virol. 2006 Mar; 80(6):3050-61. PMID: 16501114; PMCID: PMC1395437.